Clincosm LogoSign in Get a demo

Solid Tumors

Showing 51 - 75 of 598
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumors Trial (BGB-B167, Tislelizumab)

Not yet recruiting
  • Solid Tumors
  • (no location specified)
Dec 1, 2022

Solid Tumors Trial in Houston (Dexamethasone, Placebo)

Active, not recruiting
Has Results
  • Solid Tumors
  • Houston, Texas
  • +1 more
Dec 5, 2022

Solid Tumors Trial in United States (CORT125134 with nab-paclitaxel)

Completed
Has Results
  • Solid Tumors
  • Relacorilant with nab-paclitaxel
  • Scottsdale, Arizona
  • +3 more
Nov 9, 2022

Non Hodgkin Lymphoma (NHL), Peripheral T-cell Lymphoma (PTCL), Cutaneous T-Cell Lymphoma (CTCL) Trial in United States (KT-333)

Recruiting
  • Non Hodgkin Lymphoma (NHL)
  • +4 more
  • Orange, California
  • +8 more
Nov 29, 2022

Solid Tumors, Cancer Trial in Worldwide (MEDI1191, Durvalumab)

Active, not recruiting
  • Solid Tumors
  • Cancer
  • MEDI1191
  • Durvalumab
  • La Jolla, California
  • +13 more
Nov 30, 2022

Solid Tumors Trial in Australia, Korea, Republic of, United States (MEDI9447, MEDI9447 and MEDI4736)

Active, not recruiting
  • Solid Tumors
  • MEDI9447
  • MEDI9447 and MEDI4736
  • La Jolla, California
  • +17 more
Nov 21, 2022

Solid Tumors, Lymphoma Trial in Worldwide (ASTX660)

Active, not recruiting
  • Solid Tumors
  • Lymphoma
  • Birmingham, Alabama
  • +68 more
Nov 18, 2022

Melanoma, Prostate Cancer, Ovarian Cancer Trial in United States (Pegilodecakin, Paclitaxel or Docetaxel and Carboplatin or

Active, not recruiting
  • Melanoma
  • +8 more
  • Los Angeles, California
  • +9 more
Nov 15, 2022

Solid Tumors Trial in Chiba, Tokyo (INCB086550)

Terminated
  • Solid Tumors
  • Chiba, Japan
  • +1 more
Nov 14, 2022

Acute Myeloid Leukemia, Accelerated Phase Chronic Myeloid Leukemia, Blast Phase Chronic Myeloid Leukemia Trial in Worldwide

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Ghent, Belgium
  • +28 more
Nov 11, 2022

Solid Tumors Trial (afatinib)

No longer available
  • Solid Tumors
  • (no location specified)
Nov 7, 2022

Solid Tumors, Tumors, Malignant Tumor Trial in Changchun (ES102)

Active, not recruiting
  • Solid Tumors
  • +2 more
  • Changchun, Jilin, China
    Jilin Cancer Hospital
Oct 19, 2022

Solid Tumors, Identified by NGS, PCR or IHC Trial in United States (Pembrolizumab)

Recruiting
  • Solid Tumors
  • Identified by NGS, PCR or IHC
  • Basking Ridge, New Jersey
  • +6 more
Oct 7, 2022

Solid Tumors Trial in Kashiwa, Suita, Chuo Ku (S-531011, Pembrolizumab)

Recruiting
  • Solid Tumors
  • Los Angeles, California
  • +5 more
Oct 6, 2022

Solid Tumors, Lung Adenocarcinoma, Osteosarcoma Trial in Tianjin (IBI188, GM-CSF, Cisplatin/Carboplatin)

Terminated
  • Solid Tumors
  • +2 more
  • Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Oct 3, 2022

Solid Tumors Trial in United States (mRNA-4157, Pembrolizumab)

Recruiting
  • Solid Tumors
  • mRNA-4157
  • Pembrolizumab
  • Tucson, Arizona
  • +9 more
Sep 20, 2022

Solid Tumors Trial in Canada, United Kingdom (cediranib)

Active, not recruiting
  • Solid Tumors
  • Edmonton, Alberta, Canada
  • +4 more
Sep 20, 2022

Solid Tumors Trial in Singapore, United States (ETC-1922159, Pembrolizumab)

Recruiting
  • Solid Tumors
  • Tucson, Arizona
  • +10 more
Sep 16, 2022

Solid Tumors, NSCLC, CRC Trial in United States (Telaglenestat (CB-839), Palbociclib Oral Capsule or Tablet [Ibrance])

Completed
  • Solid Tumors
  • +3 more
  • Telaglenestat (CB-839)
  • Palbociclib Oral Capsule or Tablet [Ibrance]
  • Santa Monica, California
  • +9 more
Sep 14, 2022

Solid Tumors Trial in Worldwide (Cobimetinib)

Completed
Has Results
  • Solid Tumors
  • Little Rock, Arkansas
  • +16 more
Sep 14, 2022

Recurrent Endometrial Cancer, Solid Tumors Trial in Pittsburgh (pembrolizumab, Sitravatinib)

Recruiting
  • Recurrent Endometrial Cancer
  • Solid Tumors
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 12, 2022

Clear Cell Renal Cell Carcinoma, Solid Tumors Trial (AB521)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • Solid Tumors
  • (no location specified)
Sep 7, 2022

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Solid Tumors Trial in New York (procedure, drug, device, genetic)

Active, not recruiting
  • Solid Tumors
  • Production of Genetically-modified T cells
  • +4 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 1, 2022

Solid Tumors Trial (8MW2311)

Recruiting
  • Solid Tumors
  • Bengbu, Anhui, China
  • +2 more
Aug 29, 2022